down arrow

EUDA Health Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VGG3142E1051
USD
2.64
0.02 (0.76%)

Dec 18

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

2.592.89

52 Week

1.035.43
Valuation
Technical
Day's Volume

CASH

56.07 k

Shareholding (Dec 2024)

FII

0.16%

Held by 2 FIIs

DII

99.8%

Held by 0 DIIs

Promoter

0.00%

How big is EUDA Health Holdings Ltd.?

22-Jun-2025

As of Jun 18, EUDA Health Holdings Ltd. has a market capitalization of 133.95 million, classifying it as a Micro Cap company. As of Jun 23, the company reported net sales of 2.81 million and a consolidated net profit of -9.33 million.

As of Jun 18, EUDA Health Holdings Ltd. has a market capitalization of 133.95 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 23, the company reported net sales of 2.81 million for the latest four quarters. During the same period, the consolidated net profit was recorded at -9.33 million.<BR><BR>As of Dec 24, the shareholder's funds were reported at -2.55 million, while total assets stood at 1.73 million.

Read More

What does EUDA Health Holdings Ltd. do?

22-Jun-2025

EUDA Health Holdings Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $6 million as of June 2023, with a market cap of $133.95 million. Key metrics include a negative P/E ratio and a return on equity of 95.35%.

Overview:<BR>EUDA Health Holdings Ltd. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1 Million (Quarterly Results - Jun 2023) <BR>Most recent Net Profit: -6 Million (Quarterly Results - Jun 2023) <BR>Market-cap: USD 133.95 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.51 <BR>Return on Equity: 95.35% <BR>Price to Book: -52.47 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is EUDA Health Holdings Ltd. overvalued or undervalued?

25-Jun-2025

As of May 10, 2023, EUDA Health Holdings Ltd. is considered risky and overvalued, with significant negative financial ratios and a year-to-date return of -20%, contrasting sharply with the S&P 500's gain of 2.44%.

As of 10 May 2023, the valuation grade for EUDA Health Holdings Ltd. has moved from does not qualify to risky. The company appears to be overvalued given its significant negative ratios, including a Price to Book Value of -50.06 and an EV to EBITDA of -53.53. The current price of $3.58 is notably higher than its 52-week low of $2.83, but the overall financial metrics suggest a concerning outlook.<BR><BR>In comparison to its peers, EUDA Health Holdings Ltd. has a P/E ratio of -55.03, while GeneDx Holdings Corp. shows a P/E of -63.58 and Personalis, Inc. has a P/E of -6.55. This indicates that EUDA is not only underperforming relative to its peers but also struggling with negative returns on capital. The company's year-to-date return of -20% starkly contrasts with the S&P 500's gain of 2.44%, reinforcing the notion that EUDA is overvalued in its current state.

Read More

Is EUDA Health Holdings Ltd. technically bullish or bearish?

20-Sep-2025

As of August 6, 2025, EUDA Health Holdings Ltd. has shifted to a bearish trend, supported by bearish signals from the weekly MACD, Bollinger Bands, and daily moving averages, despite a bullish weekly RSI, and has underperformed the S&P 500 with a year-to-date return of -74.86%.

As of 6 August 2025, the technical trend for EUDA Health Holdings Ltd. has changed from mildly bearish to bearish. The current technical stance is bearish with a strong indication from the weekly MACD and Bollinger Bands both showing bearish signals. The daily moving averages also confirm a bearish outlook. The weekly RSI is bullish, but this is overshadowed by the overall bearish sentiment from other indicators. Additionally, the stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -74.86% versus the S&P's 12.22%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 56 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.51

stock-summary
Return on Equity

95.35%

stock-summary
Price to Book

-21.83

Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2023)
Net Profit:
-6 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
134.67%
0%
134.67%
6 Months
-29.22%
0%
-29.22%
1 Year
-50.84%
0%
-50.84%
2 Years
112.9%
0%
112.9%
3 Years
47.49%
0%
47.49%
4 Years
-72.7%
0%
-72.7%
5 Years
0%
0%
0.0%

EUDA Health Holdings Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-50.10%
EBIT Growth (5y)
18.57%
EBIT to Interest (avg)
-2.99
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
6.16
Tax Ratio
0.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.12%
ROCE (avg)
0
ROE (avg)
18.47%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-50.06
EV to EBIT
-49.93
EV to EBITDA
-53.53
EV to Capital Employed
-82.06
EV to Sales
32.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 1 Schemes (0.04%)

Foreign Institutions

Held by 2 Foreign Institutions (0.16%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by EUDA Health Holdings Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.11% vs -62.24% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -109.52% vs 66.27% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.00",
          "val2": "3.70",
          "chgp": "8.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.40",
          "val2": "-3.80",
          "chgp": "36.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-15.20",
          "val2": "-4.60",
          "chgp": "-230.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.60",
          "val2": "-8.40",
          "chgp": "-109.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-643.10%",
          "val2": "-1,068.70%",
          "chgp": "42.56%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
4.00
3.70
8.11%
Operating Profit (PBDIT) excl Other Income
-2.40
-3.80
36.84%
Interest
0.00
0.00
Exceptional Items
-15.20
-4.60
-230.43%
Consolidate Net Profit
-17.60
-8.40
-109.52%
Operating Profit Margin (Excl OI)
-643.10%
-1,068.70%
42.56%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 8.11% vs -62.24% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -109.52% vs 66.27% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About EUDA Health Holdings Ltd. stock-summary
stock-summary
EUDA Health Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."